Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

373

HTML

2437

Figures (1-3)

202

Tables (1-5)

202

Sum=3214

Sep 15, 2003 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Sep 15, 2003; 9(9): 1940-1945
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1940

Full Size Figure Download Figure

Figure 3 Numerical change of mouse celiac macrophages and peripheral blood mononuclear cells (PBMC) after injection of MMC.

Citation: Zhang GM, Yang Y, Huang B, Xiao H, Li D, Feng ZH. Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma. World J Gastroenterol 2003; 9(9): 1940-1945
URL: https://www.wjgnet.com/1007-9327/full/v9/i9/1940.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i9.1940